We are live on ! Find out more
VIA

Vident Investment Advisory Portfolio holdings

AUM $2.9B
1-Year Est. Return 24.67%
This Fund
S&P 500
This Quarter Est. Return
-16.08%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
–
AUM
$1.79B
AUM Growth
-$769M
Cap. Flow
-$325M
Cap. Flow %
-18.19%
Top 10 Hldgs %
13.27%
Holding
993
New
75
Increased
285
Reduced
405
Closed
227

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$22.8M
2
GMED icon
Globus Medical
GMED
+$13.6M
3
MTLS
Materialise
MTLS
+$13.3M
4
ABB
ABB Ltd
ABB
+$13.1M
5
BEAT
BioTelemetry, Inc.
BEAT
+$11.5M

Top Sells

Rank Stock Value
1
ZBRA icon
Zebra Technologies
ZBRA
+$12.4M
2
ISRG icon
Intuitive Surgical
ISRG
+$10.6M
3
XLNX
Xilinx Inc
XLNX
+$9.57M
4
VAR
Varian Medical Systems, Inc.
VAR
+$9.34M
5
ROK icon
Rockwell Automation
ROK
+$8.77M

Sector Composition

Rank Sector Weight
1 Technology 25.01%
2 Healthcare 13.46%
3 Industrials 11.37%
4 Consumer Discretionary 8%
5 Financials 6.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JRI icon
276
Nuveen Real Asset Income & Growth Fund
JRI
$352M
$1.82M 0.1%
133,638
-1,845
-1% -$27.3K
MGLN
277
DELISTED
Magellan Health Services, Inc.
MGLN
$1.82M 0.1%
32,014
-2,634
-8% -$162K
DOC icon
278
Healthpeak Properties
DOC
$14.8B
$1.82M 0.1%
65,151
+12,447
+24% +$345K
KEM
279
DELISTED
KEMET Corporation
KEM
$1.79M 0.1%
102,237
-14,341
-12% -$268K
MU icon
280
Micron Technology
MU
$991B
$1.79M 0.1%
56,303
-9,617
-15% -$365K
CHS
281
DELISTED
Chicos FAS, Inc.
CHS
$1.78M 0.1%
316,623
-72,901
-19% -$508K
STLD icon
282
Steel Dynamics
STLD
$37.6B
$1.77M 0.1%
58,934
-7,864
-12% -$297K
AAWW
283
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
$1.76M 0.1%
41,837
-5,877
-12% -$301K
EXC icon
284
Exelon
EXC
$47B
$1.76M 0.1%
54,657
+6,296
+13% +$201K
CPT icon
285
Camden Property Trust
CPT
$11.3B
$1.75M 0.1%
19,930
+2,742
+16% +$251K
CNDT icon
286
Conduent
CNDT
$264M
$1.75M 0.1%
164,534
-15,948
-9% -$248K
IBM icon
287
IBM
IBM
$224B
$1.74M 0.1%
16,033
+4,989
+45% +$599K
WPG
288
DELISTED
Washington Prime Group Inc.
WPG
$1.74M 0.1%
39,752
-5,575
-12% -$312K
ADAP
289
DELISTED
Adaptimmune Therapeutics
ADAP
$1.72M 0.1%
298,850
+106,599
+55% +$787K
WDC icon
290
Western Digital
WDC
$150B
$1.72M 0.1%
61,453
-3,734
-6% -$132K
CBM
291
DELISTED
Cambrex Corporation
CBM
$1.71M 0.1%
45,400
-6,364
-12% -$322K
LM
292
DELISTED
Legg Mason, Inc.
LM
$1.71M 0.1%
66,996
-13,963
-17% -$391K
REGN icon
293
Regeneron Pharmaceuticals
REGN
$80.8B
$1.69M 0.09%
4,521
+3,209
+245% +$1.17M
DIOD icon
294
Diodes
DIOD
$4.84B
$1.68M 0.09%
52,215
-7,314
-12% -$234K
KFY icon
295
Korn Ferry
KFY
$4.28B
$1.67M 0.09%
42,157
-5,911
-12% -$266K
XHR
296
Xenia Hotels & Resorts
XHR
$1.79B
$1.66M 0.09%
96,662
-12,593
-12% -$256K
ACHC icon
297
Acadia Healthcare
ACHC
$2.94B
$1.66M 0.09%
64,638
-6,504
-9% -$225K
AIV
298
Aimco
AIV
$383M
$1.65M 0.09%
282,916
+39,673
+16% +$236K
MRTX
299
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$1.64M 0.09%
38,607
-8,974
-19% -$358K
ALLO icon
300
Allogene Therapeutics
ALLO
$694M
$1.63M 0.09%
+60,682
New +$1.61M
10 11
12
13 14

Similar funds

EST
EA Series Trust Havertown, Pennsylvania $2.84B AUM
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
AWS
AJ Wealth Strategies New York $2.07B AUM 10.86% 1-Year Est. Return
WI
Winder Investment Singapore $4.4B AUM 8.87% 1-Year Est. Return
JP
Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return
VCM
Vigilant Capital Management Portland, Maine $1.34B AUM 15.33% 1-Year Est. Return
FCB
First Command Bank Fort Worth, Texas $1.06B AUM 10.74% 1-Year Est. Return
FCFS
First Command Financial Services Fort Worth, Texas $1.06B AUM 10.74% 1-Year Est. Return

Vident Investment Advisory's Q4 2018 Portfolio in Review

As of Q4 2018, Vident Investment Advisory held 993 positions worth $1.79B, down 30% from $2.55B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Vident Investment Advisory withdrew a net $325M in Q4 2018, closing 227 positions and reducing 405 holdings. Its most notable exit was Lazard, an estimated $3.82M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Vident Investment Advisory opened a new position in Globus Medical worth $11.8M.

  • Vident Investment Advisory's largest Q4 2018 buy was Globus Medical: 272,897 shares worth $11.8M.
  • Vident Investment Advisory added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $22.8M increase.
  • Vident Investment Advisory's biggest Q4 2018 reduction was Zebra Technologies, cutting an estimated $12.4M.
  • Vident Investment Advisory fully exited Lazard in Q4 2018, selling an estimated $3.82M.
  • Vident Investment Advisory's ten largest holdings make up 13% of its $1.79B portfolio in Q4 2018.
  • Vident Investment Advisory opened 75 new positions and closed 227 in Q4 2018.
  • Vident Investment Advisory's portfolio value fell 30% quarter-over-quarter to $1.79B.

Based on Vident Investment Advisory's 13F filing for Q4 2018, filed 14 Feb 2019.